692 related articles for article (PubMed ID: 17172717)
21. Inhibition of Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 reduces the severity of collagen-induced arthritis.
Tanaka K; Horikawa T; Suzuki S; Kitaura K; Watanabe J; Gotoh A; Shiobara N; Itoh T; Yamane S; Suzuki R; Fukui N; Ochi T
J Rheumatol; 2008 Dec; 35(12):2316-24. PubMed ID: 19004048
[TBL] [Abstract][Full Text] [Related]
22. The mouse model of collagen-induced arthritis.
Brand DD; Kang AH; Rosloniec EF
Methods Mol Med; 2004; 102():295-312. PubMed ID: 15286392
[TBL] [Abstract][Full Text] [Related]
23. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases.
Shoda H; Fujio K; Yamaguchi Y; Okamoto A; Sawada T; Kochi Y; Yamamoto K
Arthritis Res Ther; 2006; 8(6):R166. PubMed ID: 17078892
[TBL] [Abstract][Full Text] [Related]
24. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis.
Saito H; Kojima T; Takahashi M; Horne WC; Baron R; Amagasa T; Ohya K; Aoki K
Arthritis Rheum; 2007 Apr; 56(4):1164-74. PubMed ID: 17393436
[TBL] [Abstract][Full Text] [Related]
25. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis.
Matsui T; Nakata N; Nagai S; Nakatani A; Takahashi M; Momose T; Ohtomo K; Koyasu S
J Nucl Med; 2009 Jun; 50(6):920-6. PubMed ID: 19443596
[TBL] [Abstract][Full Text] [Related]
27. Biphasic regulation of the development of murine type II collagen-induced arthritis by interleukin-12: possible involvement of endogenous interleukin-10 and tumor necrosis factor alpha.
Kasama T; Yamazaki J; Hanaoka R; Miwa Y; Hatano Y; Kobayashi K; Negishi M; Ide H; Adachi M
Arthritis Rheum; 1999 Jan; 42(1):100-9. PubMed ID: 9920020
[TBL] [Abstract][Full Text] [Related]
28. [Pathology and progression of intra-articular inflammation in rheumatoid arthritis].
Geiler G
Verh Dtsch Ges Pathol; 1996; 80():46-57. PubMed ID: 9065054
[TBL] [Abstract][Full Text] [Related]
29. Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor alpha, interleukin-1beta, and interleukin-8 from peripheral blood monocytes via Fc gamma receptor IIA: a potential pathophysiologic mechanism for humoral anti-type II collagen immunity in arthritis.
Mullazehi M; Mathsson L; Lampa J; Rönnelid J
Arthritis Rheum; 2006 Jun; 54(6):1759-71. PubMed ID: 16736518
[TBL] [Abstract][Full Text] [Related]
30. The TNF-alpha transgenic mouse model of inflammatory arthritis.
Li P; Schwarz EM
Springer Semin Immunopathol; 2003 Aug; 25(1):19-33. PubMed ID: 12904889
[TBL] [Abstract][Full Text] [Related]
31. Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS.
Lee EK; Kang SM; Paik DJ; Kim JM; Youn J
Int Immunol; 2005 Mar; 17(3):325-33. PubMed ID: 15684036
[TBL] [Abstract][Full Text] [Related]
32. Collagen-induced arthritis in mice.
Williams RO
Methods Mol Med; 2007; 136():191-9. PubMed ID: 17983149
[TBL] [Abstract][Full Text] [Related]
33. Immune modulation of collagen-induced arthritis by intranasal cytokine gene delivery: a model for the therapy of rheumatoid arthritis.
Woods AM; Thompson SJ; Wooley PH; Panayi G; Klavinskis LS
Arthritis Rheum; 2005 Dec; 52(12):3761-71. PubMed ID: 16329091
[TBL] [Abstract][Full Text] [Related]
34. Anti-type II collagen antibody accelerates arthritis via CXCR2-expressing cells in IL-1 receptor antagonist-deficient mice.
Kagari T; Tanaka D; Doi H; Iwakura Y; Shimozato T
Eur J Immunol; 2007 Oct; 37(10):2753-63. PubMed ID: 17823985
[TBL] [Abstract][Full Text] [Related]
35. Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody.
Mauri C; Chu CQ; Woodrow D; Mori L; Londei M
J Immunol; 1997 Nov; 159(10):5032-41. PubMed ID: 9366431
[TBL] [Abstract][Full Text] [Related]
36. Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis.
Nandakumar KS; Holmdahl R
Arthritis Res Ther; 2006; 8(6):223. PubMed ID: 17254316
[TBL] [Abstract][Full Text] [Related]
37. Role of TL1A in the pathogenesis of rheumatoid arthritis.
Zhang J; Wang X; Fahmi H; Wojcik S; Fikes J; Yu Y; Wu J; Luo H
J Immunol; 2009 Oct; 183(8):5350-7. PubMed ID: 19786547
[TBL] [Abstract][Full Text] [Related]
38. Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies.
Malfait AM; Williams RO; Malik AS; Maini RN; Feldmann M
Arthritis Rheum; 2001 May; 44(5):1215-24. PubMed ID: 11352257
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
40. Clonotypic analysis of T cells accumulating at arthritic lesions in HTLV-I env-pX transgenic rats.
Sugaya T; Ishizu A; Ikeda H; Nakamaru Y; Fugo K; Higuchi M; Yamazaki H; Imai K; Yoshiki T
Exp Mol Pathol; 2002 Feb; 72(1):56-61. PubMed ID: 11784123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
